![Donnie Rudd](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Donnie Rudd
Geen lopende functies
Profiel
Dr. Donnie Rudd is Chief Scientific Officer at Regenetech, Inc. and Chief Scientist & Director-Intellectual Property at Endonovo Therapeutics, Inc.
He received his undergraduate degree from Texas A&M University and a graduate degree from the Chicago-Kent College of Law.
Eerdere bekende functies van Donnie Rudd
Bedrijven | Functie | Einde |
---|---|---|
ENDONOVO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Regenetech, Inc.
![]() Regenetech, Inc. Miscellaneous Commercial ServicesCommercial Services Regenetech, Inc. develops and distributes tissue regeneration technology. It provides research and development services for adult stem cells expansion and therapeutic applications. The firm offers umbilical cord and peripheral blood expansion, bone regeneration, and biomolecules producing therapeutic technologies. The company was founded in April, 2002 and is headquartered in Houston, TX. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Donnie Rudd
Texas A&M University | Undergraduate Degree |
Chicago-Kent College of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ENDONOVO THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Regenetech, Inc.
![]() Regenetech, Inc. Miscellaneous Commercial ServicesCommercial Services Regenetech, Inc. develops and distributes tissue regeneration technology. It provides research and development services for adult stem cells expansion and therapeutic applications. The firm offers umbilical cord and peripheral blood expansion, bone regeneration, and biomolecules producing therapeutic technologies. The company was founded in April, 2002 and is headquartered in Houston, TX. | Commercial Services |